Opposing effects of immunotherapy in melanoma using multisubtype interferon-alpha – can tumor immune escape after immunotherapy accelerate disease progression?-Reference-Cited by-同舟云学术

Opposing effects of immunotherapy in melanoma using multisubtype interferon-alpha – can tumor immune escape after immunotherapy accelerate disease progression?

Published:2015-10-29 Issue:3 Volume:5 Page:e1091147
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Strannegård Örjan,Thorén Fredrik B.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1091147

Reference20 articles.

1. Cancer--A Biological Approach: III. Viruses Associated with Neoplastic Conditions. IV. Practical Applications

2. Hallmarks of Cancer: The Next Generation

3. Interferons, immunity and cancer immunoediting

4. Cancer immunoediting: from immunosurveillance to tumor escape

5. Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSEUDOPROGRESSION AND HYPERPROGRESSION SECONDARY TO IMMUNOTHERAPY IN LUNG CANCER;WORLD CANCER RES J;2023

2. Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis;Frontiers in Oncology;2022-08-03

3. Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy;Cells;2022-05-27

4. Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy;Neoplasia;2021-10

5. Double-edged effects of interferons on the regulation of cancer-immunity cycle;OncoImmunology;2021-01-01